Option chain shows key data for electroCore's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for electroCore.

electroCore (NASDAQ:ECOR) Stock, Option Chain

electroCore

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Long Ideas

News

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

CURO

DBVT

ECOR

The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

DBV Technologies And 3 Other Penny Stocks Insiders Are Buying

Cannabis

electroCore, Inc.’s (NASDAQ: ECOR) gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain management and perfor

NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation - Which Is Better To Alleviate Concussion Symptoms

BEEM

CJJD

GETY

GNUS

MLGO

PXMD

SHIP

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.

High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.

10 Short Squeeze Candidates: Getty Images, Genius Brands, Lannett And More

electroCore Inc

ELCORA ADVANCED MAT ORD by Elcora Advanced Materials Corp.

Elcora Advanced Materials Corp

ECORA RESOURCES U/ADR by ECORA RESOURCES PLC

ECORA RESOURCES PLC by ECORA RESOURCES PLC

Ecora Resources PLC

Piper Sandler analyst Kashy Harrison downgrades Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) from Overweight to Neutral and lowers the price target from $23 to $11.

Downgrades

Price Target

Analyst Ratings

Piper Sandler Downgrades Sunrun to Neutral, Lowers Price Target to $11

<a href="https://www.hollywoodreporter.com/movies/movie-features/wicked-box-office-gladiator-previews-1236069327/">https://www.hollywoodreporter.com/movies/movie-features/wicked-box-office-gladiator-previews-1236069327/</a>
Call it whatever you want &mdash; Glicked, Wikiator or Barbienheimer 2.0. The only thing that matters is that the domestic <a href="https://www.hollywoodreporter.com/t/box-office/">box office</a> is <a href="https://www.hollywoodreporter.com/movies/movie-news/moana-2-tracking-record-thanksgiving-opening-1236055787/">springing back to life in historic fashio</a>n thanks to the combo of Universal&#39;s musical <a href="https://www.hollywoodreporter.com/t/wicked/">Wicked</a> and Paramount&#39;s <a href="https://www.hollywoodreporter.com/t/gladiator-ii/">Gladiator II</a>.
Fueled largely by females, Wicked grossed a huge $11 million in Thursday previews from 3,3000 cinemas for a total preview tally of $19.2 million when factoring in special advance screenings held over the past week. On Monday, Amazon Prime screenings generated $2.5 million at 750 theaters, while advance screenings on Wednesday generated another $5.7 million from 2,000 theaters.
Filmmaker Jon M. Chu&#39;s adaptation of the popular Broadway musical boasts a high-profile cast led by <a href="https://www.hollywoodreporter.com/t/ariana-grande/">Ariana Grande</a> and Cynthia Erivo, and should score one of the top opening of all time for a musical, and particularly a live-action musical (think anywhere from $85 million to $150 million). That&#39;s good news for the genre, which has a decidedly mixed record. It&#39;s also good news for Universal, which took a major gamble in making two movies. Wicked II hits theaters a year from now.
The $150 film was originally set to open Nov. 27, the day before Thanksgiving, but moved up to build word of mouth heading into Thanksgiving week. The new date also allows gives it some breathing room from Disney&#39;s <a href="https://www.hollywoodreporter.com/t/moana-2/">Moana 2</a>, which sails into theaters on the 27th. Moana 2 is likewise looking like a monster and is expected to lead the biggest five-day holiday weekend of all time (Wednesday through Sunday).
Social media has been abuzz with speculation that Gladiator II and Wicked will replicate the Barbenheimer effect this weekend and be the perfect pairing in terms of attracting males and females to the multiplex. Wicked presently boasts an 89 percent fresh ratings critics score on Rotten Tomatoes and Gladiator, 72 percent.
Originally based on the best-selling novel by Gregory Maguire &mdash; Wicked tells the untold story of the witches of Oz, with Erivo as Elphaba and Grande as Glinda. Winnie Holzman, the stage production&#39;s book writer, wrote the screenplay for Chu&#39;s movie with Dana Fox. Academy Award-winning composer and lyricist Stephen Schwartz adapted the musical for the screen.
Directed by Ridley Scott, the $250 million Gladiator sequel opens 24 years after the first film and is looks to open to hearty $65 million or thereabouts. The follow-up stars Paul Mescal, <a href="https://www.hollywoodreporter.com/t/denzel-washington/">Denzel Washington</a>, Connie Nielsen and Fred Hechinger, among others.
&nbsp;
<a href="https://www.hollywoodreporter.com/movies/movie-news/gladiator-2-trailer-paul-mescal-1236009553/">The film </a>sees Mescal playing a grown-up Lucius Verus II, a nephew of Emperor Commodus from the original film, played by Joaquin Phoenix. Lucius returns to Rome after being forced into slavery to battle not as a ruler but as a gladiator out for revenge and power, seeking to return the glory of Rome to its people.

CMCSA

IMAX

PARA

"Box Office: 'Wicked' Earns Huge $19M From Week-Long Previews, 'Gladiator II' Soars to $6.5M on Thursday Alone" - Hollywood Reporter

WIIM

ONDS

Ondas shares are trading higher after the company announced it received a purchase order for the iron drone raider counter-drone system from an Israeli defense company.

INDP

Indaptus Therapeutics shares are trading lower. The company announced a $2.135 million direct offering and private placement.

RBC Capital analyst Deane Dray maintains Atkore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATKR#NYSE">ATKR</a>) with a Sector Perform and lowers the price target from $99 to $93.

ATKR

RBC Capital Maintains Sector Perform on Atkore, Lowers Price Target to $93

Scotiabank analyst Tomas Gonzalez downgrades Enel Chile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENIC#NYSE">ENIC</a>) from Sector Outperform to Sector Perform and maintains the price target from $3.9 to $3.9.

ENIC

Scotiabank Downgrades Enel Chile to Sector Perform, Maintains Price Target to $3.9

Macro Economic Events

Politics

Economics

General

HOOD

Robinhood Chief Legal Officer Dan Gallagher Says Not Interested In Being Considered For The U.S. SEC Chair Role

Although Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is up over 190% year-to-date, &#8220;over the last five months the stock has been relatively flat, leaving bulls and bears at an inflection point,&#8221; <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40652895/exclusive-beyond-the-magnificent-seven-direxions-egilinsky-reveals-top-sector-picks">Direxion&#8216;s Ed Egilinsky says</a>.
This pause in growth signals the stock might be priced to perfection. Some active traders are watching for the next move. 
For those who consider the stock&#8217;s price is perfection and forward expectations are not lofty enough to propel it higher, the Direxion Daily NVDA Bear 1X Shares ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDD#NASDAQ">NVDD</a>) offers a way to get profit from any expected correction in the stock. 
However, traders who believe the stock will trend higher in the short term, can look to trade the Direxion Daily NVDA Bull 2X Shares ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDU#NASDAQ">NVDU</a>).
Read Also: <a href="https://www.benzinga.com/news/global/24/11/42129914/jim-cramer-doubles-down-on-nvidia-demand-is-accelerating-as-ai-customers-have-no-choice-but-to-buy-its-chips">Jim Cramer Doubles Down On Nvidia: &#8216;Demand Is Accelerating&#8217; As AI Customers &#8216;Have No Choice&#8217; But To Buy Its Chips</a>
<h2 class="wp-block-heading">Potential R&amp;D Spending Not Baked In</h2>
While Nvidia remains the barometer for the AI space, Egilinsky stresses the importance of continued innovation to retain its competitive edge in AI chips. 
&#8220;This could result in a more sizable commitment to their R&amp;D spending that might not be totally baked into current projections,&#8221; he said.
<h2 class="wp-block-heading">Geopolitical Tensions, Tariffs Could Impact Future Growth</h2>
Beyond its product and performance, Nvidia's future is increasingly shaped by geopolitical risks, particularly the U.S. tariff stance. 
&#8220;Traders will be waiting for a sign to trade the next move in Semis and for short-term traders that can be either a bullish view or bearish sentiment,&#8221; Egilinsky said.
The Donald Trump administration's policies on global trade, especially tariffs, could affect Nvidia's revenue from China and its reliance on Taiwan for chip production.
<h2 class="wp-block-heading">AI Growth Still Promising, But Tariffs Add Uncertainty</h2>
Despite these risks, Nvidia's future looks promising, especially with Blackwell shipments ramping up next quarter. 
One way to gauge Nvidia's AI growth prospects is by looking at its key customers like Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>). 
These tech giants rely heavily on Nvidia's chips to power their cloud platforms, machine learning, and data centers. As these companies expand their AI operations, Nvidia's role in driving this growth could bolster its position in the market, fueling continued demand for its products.
Egilinsky said the excessive demand for Nvidia&#8217;s products might &#8220;send the stock to new all-time highs.&#8221; Still, the company's ability to navigate geopolitical hurdles will be crucial to sustaining this growth.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/earnings-beats/24/11/42121215/nvidia-post-earnings-jitters-can-nvda-stock-regain-its-ai-fueled-momentum">Nvidia&#8217;s Post-Earnings Jitters: Can NVDA Stock Regain Its AI-Fueled Momentum?</a></li>
</ul>

Analyst Color

AMZN

MSFT

NVDA

NVDD

NVDU

Nvidia 'Bulls And Bears At An Inflection Point,' Expert Says: Will AI Growth Overcome Global Tariff Risks?

<a href="https://www.ft.com/content/739bed04-fce1-4429-bbfd-64979e6bf395">https://www.ft.com/content/739bed04-fce1-4429-bbfd-64979e6bf395</a>

'Unilever To Slim Down But Not Spin Off Food Business, Says Chief' - Financial Times

RBC Capital analyst Rishi Jaluria maintains Clearwater Analytics Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWAN#NYSE">CWAN</a>) with a Outperform and raises the price target from $32 to $36.

CWAN

RBC Capital Maintains Outperform on Clearwater Analytics Hldg, Raises Price Target to $36

Nano Labs shares are trading higher after the company announced it unveiled a second-generation of v series crypto mining products with 5x the power efficiency.

QMCO

Quantum Shares Halted On Circuit Breaker To The Downside, Stock Now Up 52.2%

Nutanix's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NYSE">NTNX</a>) short percent of float has fallen 11.79% since its last report. The company recently reported that it has 4.65 million shares sold short, which is 2.02% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.46 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Nutanix Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732290320_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Nutanix has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Nutanix's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Nutanix's peer group average for short interest as a percentage of float is 3.38%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

NTNX

(NTNX) - Analyzing Nutanix's Short Interest

LIFW

MSP Recovery shares are trading higher after the company announced it secured a $2 million pharmaceutical settlement.

CSW Industrials's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSWI#NYSE">CSWI</a>) short percent of float has fallen 20.0% since its last report. The company recently reported that it has 397 thousand shares sold short, which is 2.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.88 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>CSW Industrials Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732290315_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CSW Industrials has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing CSW Industrials's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, CSW Industrials's peer group average for short interest as a percentage of float is 3.71%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CSWI

(CSWI) - Analyzing CSW Industrials's Short Interest

New York&#8217;s storied real estate dynasties are breaking a rule passed down through generations – never sell your buildings. As the <a href="https://www.benzinga.com/real-estate/24/10/41357339/experts-warn-that-distress-in-u-s-offices-may-lead-to-a-surging-supply-of-one-billion-square-feet-of">office market crumbles under the weight of remote work</a>, New York families are forced to part with properties they&#8217;ve held for decades.
William Rudin, whose family helped shape Manhattan&#8217;s skyline, recently sold control of two financial district towers his family developed in the 1960s. "The world has changed," Rudin, the co-executive chairman of his family's firm, told the Wall Street Journal. "We have to take a cold hard look at our business to make sure there's a foundation for the next generation."
Don't Miss:
<ul>
<li>Invest in $20+ trillion home equity market today across cities like Austin, Miami, and Los Angeles through a <a href="https://www.benzinga.com/money/nada-cityfunds">unique 5-year term fund targeting a 14-20% IRR with minimums as low as $2,500</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
</ul>
The sales mark a shift for families that have weathered world wars, financial crashes and even a pandemic without letting go of their core assets. According to real estate investment firm Eastdil Secured, New York&#8217;s real estate families have sold about 10 office buildings in the past two years – double the number sold in the previous decade.
"Instead of 50 different aunts and uncles getting distributions, they're getting capital calls," Gary Phillips, an Eastdil managing director, told the WSJ, highlighting the financial strain on extended family businesses.
With a 100-year legacy in Manhattan real estate, the Kaufman family is also reluctantly selling. "We and the other families did not sell," Jonathan Iger, CEO of Sage Realty, the Kaufman family's management firm, said to the WSJ. "You see yourself through the dips and you come out – not just fine, but more than fine."
Trending: Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a>
Some families are fighting to hold on. The Gurals recently invested fresh capital into their 60-year-old DuMont Building on Madison Avenue. "It's called a capital call, which is the most dreaded term in our industry," said Jeffrey Gural, chairman of GFP Real Estate. Despite the pain, Gural remains convinced holding is the right choice. "I have yet to sell a building where I didn't regret selling," he said.
For the Rudins, even a $100 million renovation at 80 Pine Street couldn't save it from the chopping block. "Even if we spent money to fix up the building, the ceilings are too low, there are a lot of columns, the floors are too big," Rudin explained. "It became clear to us we needed to stop putting capital back into the building."
The sales represent more than just business decisions – they're the end of an era for families who built New York's commercial landscape. "When I go by 80 Pine Street, I remember the good times and bad times," Rudin reflected. "But you've got to move on."
The shift might signal a broader transformation in urban real estate, as aging office towers face obsolescence in a <a href="https://www.benzinga.com/markets/24/08/40436855/hopes-for-nyc-office-market-rebound-dented-by-sale-of-midtown-skyscraper-at-97-discount-but-theres-a">post-pandemic world demanding modern amenities and flexible workspaces</a>.
Read Next:
<ul>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>

Real Estate

'I Have Yet to Sell A Building Where I Didn't Regret Selling ': Families Forced To Sell NYC Icons

Comfort Systems USA's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) short percent of float has risen 40.65% since its last report. The company recently reported that it has 536 thousand shares sold short, which is 2.18% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.35 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Comfort Systems USA Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732290310_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Comfort Systems USA has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Comfort Systems USA's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Comfort Systems USA's peer group average for short interest as a percentage of float is 4.48%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(FIX) - Analyzing Comfort Systems USA's Short Interest

RBC Capital analyst Arun Viswanathan reiterates Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Sector Perform and maintains $105 price target.

Reiteration

RBC Capital Reiterates Sector Perform on Eastman Chemical, Maintains $105 Price Target

- Court Document
<figure class="image"><img src="https://pbs.twimg.com/media/Gc_-b5VWAAAMhj1?format=jpg&amp;name=large" alt="Image" /></figure>

Legal

New York Judge Grants Trump Permission To File Motion To Dismiss Hush Money Case, Delays Sentencing

CTXR

Citius Pharmaceuticals shares are trading lower after the company announced a 1-for-25 reverse stock split.

Here are the major earnings after the close today

ElectroCore GAAP EPS of -$0.31 beats by $0.02, revenue of $6.55M misses by $0.16M

Reports Q3 revenue $6.6M, consensus $6.49M. "Demand for our Rx gammaCore and Truvaga solutions continue to drive robust growth," commented Dan Gold...

electroCore reports Q3 EPS (31c), consensus (33c)

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER AFTER EARNINGS – DLocal (DLO)&nbsp;up 12.3% Ta...

Closing Bell Movers: Tetra Tech down 8% after Q4 results, guidance

electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript

Electrocore (ECOR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Swayampakula Ramakanth f...

Electrocore's Strong Revenue Growth and Strategic Expansion Justify Buy Rating

H.C. Wainwright raised the firm's price target on electroCore (ECOR) to $22 from $15 and keeps a Buy rating on the shares after the firm updated it...

electroCore price target raised to $22 from $15 at H.C. Wainwright

Maxim Group analyst Anthony Vendetti has reiterated their bullish stance on ECOR stock, giving a Buy rating yesterday. Anthony Vendetti has given h...

Anthony Vendetti Reiterates Buy Rating for Electrocore Amid Strong Financial Performance and Strategic Growth Initiatives

Volatile market? Learn how RCAT, ROOT, and GEO stand out with robust catalysts, sentiment, and fundamentals.

From Volatility To Opportunity: Key Stocks Poised To Shine Today

electroCore (ECOR) has donated 20 gammaCore Sapphire D's to be used by Dr. Robin Ely, Director of Integrative and Regenerative Medicine, a global p...

electroCore donates gammaCore Sapphire for real world evalution of nVNS

ADAP

AEMD

AGRO

AOIFF

ASTS

AYTU

BDORY

BNGO

BOXL

BRFS

CAPR

CSCO

DADA

DGII

DRRX

GLAD

GOEV

GRYP

HIMS

HROW

IBTA

KLIC

NLCP

OMER

OPRX

OTRK

PVCT

RCAT

ROOT

SMSI

SONO

SPRU

TARS

TLPH

TTEK

VXRT

Press Releases

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

electroCore Engages FNK IR to Execute Expanded Investor Relations Program

electroCore to Participate in Upcoming Investor Conferences

electroCore to Announce Third Quarter September 30, 2024 Financial Results on Wednesday, November 13, 2024

Management

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Health Care

ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award

Earnings

electroCore Announces Third Quarter 2024 Financial Results

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis

electroCore's Truvaga™ Plus Wins Woman's World Magazine 50 over 50 Award

Apyx Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

HeartBeam

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

CytoSorbents

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Daxor

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

electroCore

electroCore (ECOR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga